|
The device was originally submitted to the fda through initial mdr # (1416980-2024-03466) with an aware date of 06/11/2024.Additional information was received on 08/09/2024 that triggered this new initial mdr for this event.One (1) actual device and a photograph of the sample was received for evaluation.Visual inspection was performed which observed the blisters were wiped up with a substance, then the label information was illegible.The reported condition was verified.The cause of the condition could not be determined.However, the ink is water-based, therefore, contact with other liquids can result in this event.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|